Differences in preoperative variables in each outcome group
| Preoperative variables | 1 month | 12 months | ||||||
|---|---|---|---|---|---|---|---|---|
| Excellent (n = 13) | Fair (n = 3) | Poor (n = 5) | p Value (Kruskal–Wallis) | Excellent (n = 10) | Fair (n = 5) | Poor (n = 4) | p Value (Kruskal–Wallis) | |
| *Calculated after conversion to a binary value. Bold faced values are significant (p<0.05). | ||||||||
| Cho, choline compounds; Cr, creatine; HDS-R, Hasegawa’s dementia scale; mIns, myoinositol; m-Rankin, modified Rankin scale; NAA, N-acetylaspartate. | ||||||||
| Age (years) | 63 (8) | 69 (9) | 60 (10) | 0.3458* | 57 (10) | 65 (10) | 60 (3) | 0.2609* |
| Male/female | 6/7 | 0/3 | 2/3 | 0.4739* | 6/7 | 0/3 | 2/3 | 0.9560* |
| Period to shunt | 41 (17) | 49 (23) | 55 (24) | 0.2971* | 40 (17) | 52 (25) | 40 (17) | 0.4032* |
| HDS-R | 5.0 (4.8) | 0.0 (0.0) | 2.8 (5.2) | 0.2374* | 5.0 (4.8) | 0.0 (0.0) | 2.8 (5.2) | 0.6813* |
| m-Rankin | 4.1 (1.0) | 4.7 (0.6) | 4.8 (0.4) | 0.2191* | 4.1 (1.0) | 4.7 (0.6) | 4.8 (0.4) | 0.4134* |
| Gait score | 1.9 (1.4) | 1.0 (0.0) | 1.0 (0.0) | 0.5110* | 1.9 (1.4) | 1.0 (0.0) | 1.0 (0.0) | 0.6925* |
| Incontinence | 10/13 | 3/3 | 5/5 | 0.6855* | 10/13 | 3/3 | 5/5 | 0.8353* |
| NAA/Cr | 1.69 (0.20) | 1.34 (0.08) | 1.15 (0.12) | 0.0009* | 1.68 (0.24) | 1.41 (0.21) | 1.30 (0.28) | 0.0335* |
| NAA/Cho | 1.58 (0.34) | 1.28 (0.31) | 1.09 (0.21) | 0.0092* | 1.68 (0.34) | 1.21 (0.12) | 1.17 (0.17) | 0.0035* |
| Cho/Cr | 1.10 (0.17) | 1.08 (0.20) | 1.07 (0.14) | 0.8770* | 1.02 (0.18) | 1.16 (0.16) | 1.11 (0.11) | 0.3031* |
| mIns/Cr | 0.24 (0.08) | 0.29 (0.14) | 0.37 (0.10) | 0.0542* | 0.26 (0.08) | 0.25 (0.12) | 0.35 (0.12) | 0.1798* |